Home > Request Information
Title:
PharmaKure Submits MHRA CTA for Phase 2a Clinical Trial of PK051 in Patients with Mild Cognitive Impairment
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:
refresh